Your browser doesn't support javascript.
loading
Cyclodextrin-Based Arsenal for Anti-Cancer Treatments.
Chopra, Hitesh; Verma, Ravinder; Kaushik, Sakshi; Parashar, Jatin; Madan, Kumud; Bano, Afsareen; Bhardwaj, Rashmi; Pandey, Parijat; Kumari, Beena; Purohit, Deepika; Kumar, Manish; Bhatia, Saurabh; Rahman, Md Habibur; Mittal, Vineet; Singh, Inderbir; Kaushik, Deepak.
Afiliação
  • Chopra H; Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
  • Verma R; Department of Pharmacy, G.D. Goenka University, Sohna Road, Gurugram 122103, India.
  • Kaushik S; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.
  • Parashar J; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.
  • Madan K; Lloyd Institute of Management and Technology (Pharm), Knowledge Park, Greater Noida, U.P., India.
  • Bano A; Centre for Medical Biotechnology, Maharshi Dayanand University, Rohtak 124001, India.
  • Bhardwaj R; Centre for Medical Biotechnology, Maharshi Dayanand University, Rohtak 124001, India.
  • Pandey P; Department of Pharmaceutical Sciences, Gurugram University, Gurugram 122413, India.
  • Kumari B; Department of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, India.
  • Purohit D; Department of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, India.
  • Kumar M; M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala 133207, Haryana, India.
  • Bhatia S; Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Sultanate of Oman; School of Health Science, University of Petroleum and Energy Studies, Dehradun, Uttarakhand 248007, India.
  • Rahman MH; Department of Pharmacy, Southeast University, Banani, Dhaka 1213, Bangladesh.
  • Mittal V; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.
  • Singh I; Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
  • Kaushik D; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.
Article em En | MEDLINE | ID: mdl-36734912
Anti-cancer drugs are mostly limited in their use due to poor physicochemical and biopharmaceutical properties. Their lower solubility is the most common hurdle limiting their use upto their potential. In the recent years, the cyclodextrin (CD) complexation have emerged as existing approach to overcome the problem of poor solubility. CD-based nano-technological approaches are safe, stable and showed well in vivo tolerance and greater payload for encapsulation of hydrophobic drugs for the targeted delivery. They are generally chosen due to their ability to get self-assembled to form liposomes, nanoparticles, micelles and nano-sponges etc. This review paper describes a birds-eye view of the various CD-based nano-technological approaches applied for the delivery of anti-cancer moieties to the desired target such as CD based liposomes, niosomes, niosoponges, micelles, nanoparticles, monoclonal antibody, magnetic nanoparticles, small interfering RNA, nanorods, miscellaneous formulation of anti-cancer drugs containing CD. Moreover, the author also summarizes the various shortcomings of such a system and their way ahead.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclodextrinas / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclodextrinas / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article